he company's success and timing of product
development and new product introductions, including the installations of
the Volcano imaging systems, the expected performance of its products and
product enhancements, the integration of our products into new or existing
cath labs, and market penetration, conditions and expectations.
Forward-looking statements are based on management's current, preliminary
expectations and are subject to risks and uncertainties, which may cause
Volcano's results to differ materially and adversely from the statements
contained herein. Some of the potential risks and uncertainties that could
cause actual results to differ from the results predicted are detailed in
the company's annual report on Form 10-K, quarterly report on Form 10-Q,
and other filings made with the Securities and Exchange Commission. Undue
reliance should not be placed on forward-looking statements, which speak
only as of the date they are made. Volcano undertakes no obligation to
update any forward-looking statements to reflect new information, events or
circumstances after the date they were made, or to reflect the occurrence
of unanticipated events.
'/>"/>SOURCE Volcano Corporation Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 Related biology technology :1.
Volcano Corp Announces First Human Use of the Volcano Optical Coherence Tomography (OCT) Imaging Catheter2.
Volcano Reports 24 Percent Increase in First Quarter Revenues; IVUS Disposable Revenues Increase 30 Percent3.
Volcano Announces U.S. and European Launch of Rotational IVUS and Integrated FFR4.
Volcano Corporation Presentation at Cowen Healthcare Conference to be Webcast5.
Volcano Announces FDA 510(k) Clearance of Revolution Rotational Catheter and FFR for the s5i Integrated IVUS Console6.
Volcano Corporation Schedules Fourth Quarter Conference Call, Webcast7.
Volcano Announces Closing of CardioSpectra Acquisition8.
Volcano Announces Activities at TCT 2007: Expanded Role of IVUS in PCI to be Demonstrated9.
Volcano Corporation Announces Pricing of Common Stock Offering10.
Volcano Corporation Presentation at Bear Stearns Conference to be Webcast11.
NuRx Pharmaceuticals Announces Change of Ticker Symbol to NUXP, Reverse Stock Split Now in Effect